PE-208 Development of Decompensated Cardiac Hypertrophy in Transgenic Mice That Overexpress S1P1 under the Control of Alpha Smooth Muscle Actin Promoter(Cardiac hypertrophy, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2007-03-01
著者
-
Takuwa Yo
Department Physiology, Kanazawa University School of Medicine
-
Takuwa Yo
Department Of Molecular And Cellular Physiology Kanazawa University Graduate School Of Medical Scien
-
Takuwa Yoh
Graduate School Of Medical Science Kanazawa University
-
Takuwa Yoh
金沢大学 自然科学研究科
-
Sugimoto Naotoshi
金沢大学 自然科学研究科
-
Sugimoto Naotoshi
Departments Of Molecular And Cellular Physiology Kanazawa University Graduate School Of Medical Scie
-
Sugimoto Naotoshi
Graduate School Of Medical Science Kanazawa University
-
多久和 陽
金沢大学血管分子生理学
-
多久和 典子
金沢大学医学系研究科血管分子生理学
-
Takuwa Noriko
Department Of Physiology Kanazawa University
-
Takuwa Noriko
Departments Of Molecular Genetics Of Cardiovascular Disorder Graduate School Of Medical Science Kana
-
Takuwa Noriko
Departments Of Physiology And Cardiovascular Biology Faculty Of Medicine The University Of Tokyo
-
Takata Shigeo
Department Of Cardiology Kanazawa University Graduate School Of Medicine
-
Sugimoto Naotoshi
Department Of Physiology Kanazawa University Graduate School Of Medicine
-
Sugimoto Naotoshi
Departments Of Molecular Genetics Of Cardiovascular Disorder Graduate School Of Medical Science Kana
-
多久 和陽
福島県立医科大学 第一内科
-
多久 和陽
東京大学 大学院医学系研究科腫瘍外科学
-
Tanaka Shigeo
Department Of Disease Control And Homeostasis Kanazawa University
-
Sugimoto Naotoshi
Department Of Molecular Vascular Physiology Kanazawa University
-
Tanaka Shigeo
Inst. Of Nature And Environmental Technol. Kanazawa Univ.
-
Sugimoto Naotoshi
Department Of Physiology Kanazawa University
-
Takata Sigeo
金沢大学 医学系研究科循環器内科
-
Yuasa Toyoshi
金沢大学 医学系研究科恒常性制御学講座
-
Takata Shigeo
金沢大学 第1内科
-
Takuwa Yo
Graduate School Of Medical Science Kanazawa University
-
Sugimoto Naoki
Department Of Cardiology Kanazawa Municipal Hospital
-
Takashima Shinichiro
Department of Disease Control and Homeostasis, Kanazawa University
-
Ohkura Seiichiro
Department of Cardiology, Graduate School of Medicine, Kanazawa University
-
Takata Shigeo
1st. Dept. of Int. Med. Kanazawa Univ.
-
Takata Sigeo
Department Of Health Science Faculty Of Medicine Kanazawa University
-
多久和 陽
金沢大学医学系研究科血管分子生理 がん遺伝子治療学
-
多久和 陽
Graduate School Of Medical Science Kanazawa University
-
Takuwa Yo
Departments Of Molecular Genetics Of Cardiovascular Disorder Graduate School Of Medical Science Kana
-
Takata Shigeo
The 1st Department Of Internal Medicine School Of Medicine Kanazawa University
-
Ohkura Seiichiro
Department Of Cardiology Graduate School Of Medicine Kanazawa University
-
Ohkura Seiichiro
Department Of Physiology Kanazawa University Graduate School Of Medicine
-
Takuwa Yoh
Dept. Physiology Kanazawa University Sch. Of Med.
-
Takuwa Noriko
Dept. Physiology Kanazawa University Sch. Of Med.
-
Takashima Shin-ichiro
Department Of Disease Control And Homeostasis Graduate School Of Medical Science Kanazawa University
-
Takuwa Yo
Department Of Cardiology
-
Sugimoto Naotoshi
Department Of Clinical Oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Takashima Shinichiro
Department of Disease Control and Homeostasis, Graduate School of Medical Science, Kanazawa University
関連論文
- バルーン障害後再狭窄に対するPDGF-Bを標的とした治療の可能性
- (1)新しい増殖因子Gas6のバルーン障害後新生内膜形成における関与
- 1034 バルーン血管拡張術後の新生内膜肥厚に対するPDGFを標的とした遺伝子治療法の開発
- MMP阻害は酸化LDLによるRhoA依存性eNOS発現低下を抑制する(第139回日本循環器学会東北地方会)
- トロンビン刺激血管内皮細胞のRhoA活性化におけるゲラニルゲラニル化の重要性(第139回日本循環器学会東北地方会)
- PE-086 New Insights into Oxidized LDL-induced RhoA and Rac1 Activation by an LOX-1-MT1-MMP Axis in Endothelial Dysfunction(Endothelium(02)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- S1P2遺伝ヘテロ欠損マウスに発生した腎複合上皮間質腫瘍の一例(病理学)
- Balloon injury後の血管平滑筋細胞増殖に伴うcdc2キナーゼ活性化 : 口述発表 : 第57回日本循環器学会学術集会
- S1P_2受容体によるがん血管新生抑制とそのメカニズム
- P329 バルーン障害ラット頚動脈におけるPDGF受容体の活性化
- 0255 冠動脈アテレクトミー(DCA)標本におけるPDGF受容体の活性化 : 不安定狭心症と慢性期再狭窄との関連について
- Cigarette Smoking Augments Sympathetic Nerve Activity in Patients With Coronary Heart Disease
- 徐放化S1P製剤による虚血後血管新生の促進
- A mechanism underlying STAT4-mediated up-regulation of IFN-γ induction in TCR-triggered T cells
- Endogenous Cryogens Existing in the Blood of a Hypothermic Patient
- A young female patient suffering from hypothermia in a cool environment
- Thermoregulatory Responses to Acute Heat Loads in Rats Following Spontaneous Running
- Changes in Core Temperature and Thermoeffector Thresholds in Exercise-Trained Rats
- Lipopolysaccharide-Induced Fever in Rats Prolonged by a Needle Prick
- RhoA and Rac1 Changes in the Atherosclerotic Lesions of WHHLMI Rabbits
- Cyclic AMP prevents class IIα-isoform of phosphoinositide 3-kinase- and ROCK-dependent inhibition of myosin light chain phosphatase in vascular smooth muscle
- S1P_2受容体の細胞遊走抑制作用を仲介するRhoエフェクターの検討
- S1Pの生合成・受容体・生理的機能 (特集 脂質の新たな機能を追う)
- S1P受容体S1P_2による細胞遊走抑制はがん抑制遺伝子産物PTENに依存しない
- スフィンゴシン-1-リン酸受容体1(S1P1) トランスジェニックマウスにおける病的肥大心の発症と病態生理
- PI3キナーゼ・クラスIIαはRho活性化を介してカルシウム依存性血管平滑筋収縮を制御する
- スフィンゴシン-1-リン酸情報伝達系の虚血後血管新生における役割の検討
- スフィンゴシン キナーゼ1(SPHK1)トランスジェニックマウスにおける心筋線維化発症とその病態生理の検討
- スフィンゴシン-1-リン酸は特異的受容体S1P_2を介して血管内皮細胞の遊走、形態形成、および血管新生を抑制する
- リゾフォスファチジン酸受容体LPA_1による低分子量Rac及び細胞遊走の制御
- PI3キナーゼC2αアイソフォームは血管平滑筋収縮を制御する新規収縮シグナル伝達分子である
- 化学遊走抑制性Gたんぱく質共役型受容体SIP_2/Edg5による低分子量Gたんぱく質Racの抑制とその分子機構
- G蛋白質共役型スフィンゴシン-1-リン酸受容体S1P_2/Edg5によるRac活性および細胞遊走の抑制はG_-Rho情報伝達経路を介する
- OE-091 Involvement of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) in Advanced Glycation End Products (AGE)/RAGE-Signaling Pathways(OE16,Diabetes (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-664 LOX-1 plays a crucial role in RhoA-and Rac1-dependent signaling through Gi induced by oxidized low-density lipoprotein in endothelial cells(Molecular biology, vascular-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-197 RhoA-Dependent PAI-1 Gene Exprssion Induced in Endothelial Cells by Monocyte Adhesion is Mediated Via Geranylgeranyl Transferase I and Ca^ Signaling(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Societ
- OJ-164 Essential Role of Rapid Geranylgeranylation from Unprocessed RhoA in RhoA Activation and Increase in Unprocessed RhoA in Atherosclerosis(Endothelium-2 (H) OJ28,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japan
- Blockade of Renin-angiotensin System (RAS) Inhibits Oxidized LDL-induced Superoxide Generation by Suppressing NADPH Oxidase Component Nox-4, p47 phox and Rac(Atherosclerosis, Basic 8 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation So
- Membrane type 1 Metalloproteinase (MT1-MMP) is Involved in the RhoA-dependent eNOS Downergulation Induced by Oxidized LDL in Endothelial Cells(Atherosclerosis, Basic 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42
- Inhibition of Matrix Metalloproteases (MMPs) Suppresses Rac/NADPH Oxidase-derived Reactive Oxygen Species (ROS) Generation in Oxidized Low Density Lipoprotein-stimuleted Endothelial Cells(Atherosclerosis, Basic 4 (IHD), The 69th Annual Scientific Meeting
- Therapeutic Effect of Intravenous Administration of Statin on eNOS Downregulation and ROS Generation in Response to Thrombin in Vivo(Cardiovascular Pharmacology, Basic/Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-582 Intravenous administration of statin prevents RhoA activation-triggered eNOS downregulation and reactive oxygen species induced by thrombin in rats(Cardiovascular Pharmacology, Basic/Clinical 5 (H) : PJ98)(Poster Session (Japanese))
- PE-216 Mechanism and Role of Geranylgeranylation in RhoA Activation in Endothelial Dysfunction(Metabolism/Biochemistry/Energetics 1 (IHD) : PE37)(Poster Session (English))
- OE-118 Inhibition of Matrix Metalloproteinases (MMPs) Suppresses the RhoA-dependent eNOS Downergulation Induced by Oxidized LDL in Endothelial Cells(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
- Rho Activation and Extracellular Signal-Regulated Kinase (ERK) Downregulation Are Crucial for eNOS Downregulation in Monocyte Adhesion to Endothelial Cells
- Thrombin-lnduced Downregulation of Endothelial Nitric Oxide Synthase (eNOS) via Rho Activation in Human Endothelial Cells :Involvement of Geranylgeranyl Transferase Activation
- Thrombin-Stimulated Ca^ Signaling Mediated via RhoA Activationin Tissue Factor (TF) and Plasminogen Activator Inhibitor-1 (PAI-1) Synthesis in Endothelial Cells
- RhoA Activation Plays an Integral Role in Tissue Factor (TF) Gene Expression
- Oxidized LDL Downregulates Endothelial Nitric Oxide Synthase (eNOS) via Rapid RhoA Activaion in Endothelial Cells
- PJ-672 G_ and G_q Coordinately Mediate S1P_2-induced Inhibition of Rac and Migration in Vascular Smooth Muscle in Rho-dependent Manner(PJ113,Atherosclerosis, Basic 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese
- OE-181 Class-IIα Phosphoinositide 3-Kinase is an Essential Regulator of Ca^-Dependent Rho Activation, Myosin Phosphatase and Contraction in Vascular Smooth Muscle Cells(Vascular smooth muscle-1, The 71st Annual Scientific Meeting of the Japanese Circu
- PJ-373 Sphingosine-1-Phosphate Inhibits the Formation of Tube-Like Structures via Its Receptor EdgS in Vascular Endothelial Cells(Angiogenesis 3 (IHD) : PJ62)(Poster Session (Japanese))
- PE-348 G_q- and G_-coupled activation of Rho mediates inhibitory regulation of cellular Rac and chemotaxis in VSMCs(Molecular Biology, Vascular 3 (H) : PE59)(Poster Session (English))
- OE-012 Knockdown of Edg1 Gene Expression by RNA Interference Abolishes Sphingosine-1-Phosphate-Induced Platelet-Derived Growth Factor-B Chain Expression in Vascular Smooth Muscle Cells(Vasoactive Compound/Growth Factor/Cytokine 1 (H) : OE2)(Oral Presentat
- Sphingosine-1-Phosphate Stimulates Gene Expression of the Transcription Factor KLF5/BTEB2, Which Plays a Critical Role in PDGF-B Gene Expression, in VSMCs
- The Small GTPase Rho Mediates Sphingosine-1-Phosphate Induced Inhibition of Chemotaxis Toward PDGF through Inhibiting Rac in Vascular Smooth Muscle Cells
- The Edg Family G Protein-Coupled Receptors for Lysophospholipids: Their Signaling Properties and Biological Activities
- Roles for the small G proteins and downstream protein kinases in sphingosine-1-phosphate(S1P)-induced PDGF-B chain gene expression in VSMCs
- Current Status of Anticoagulation Therapy for Elderly Atrial Fibrillation Patients in Japan : From Hokuriku Atrial Fibrillation Trial
- PE-203 Effect of Elevated Arterial Pressure on Vascular Functional and Structural Atherosclerosis in the Hypertensive Patients(Atherosclerosis, clinical-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-183 Antiarrhythmic and Anticoagulation Therapy for Atrial Fibrillation in Japan : Hokuriku Atrial Fibrillation Trial(Arrhythmia, therapy-08, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- P327 血管内皮および血管平滑筋に発現するスフィンゴシン-1-リン酸受容体EDG3の機能解析 : EDG1, AGR16と比較して
- 0589 血管平滑筋細胞におけるRhoを介したミオシン軽鎖(MLC)フォスファターゼ活性調節のRhoキナーゼ阻害薬HA1077による抑制
- P028 Relationship between Cardiopulmonary Bororeflex Function and Sympathetic Nerve Activity in Patient with Heart Failure
- 三量体G蛋白質Ga12による細胞周期G1/S移行の促進
- PS-085-6 生理活性脂質スフィンゴシン1リン酸の肺転移抑制作用
- 血管平滑筋細胞の伸展によるJNK/SAPKの活性化 : 自己分泌ATPの関与
- THE EFFECTS OF SYMPATHETIC NERVE ACTIVITY ON VENTRICULAR RATE IN ATRIAL FIBRILLATION
- MUSCLE SYMPATHETIC NERVE RESPONSE TO PROGRAMMED VENTRICULAR PACING
- EFFECTS OF INSULIN ON SYMPATHETIC NERVOUS SYSTEM IN MAN
- A New Noninvasive and Ambulatory Monitoring Device Using Pillow's with Sleep Apnea Syndrome (Preventive Medicine/Epidemiology/Education/Health Policy 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- -0839- PARADOXICAL FOREARM VASODILATION DURING ORTHOSTATIC STRESS IN HEART FAILURE : COMPARISON TO MUSCLE SYMPATHETIC NERVE ACTIVITY(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- S-33. カルシウムイオンによるカルシウム感受性増強作用 : PI3-キナーゼクラスIIアルファの関与(血管平滑筋研究の新展開, 第49回日本平滑筋学会総会)
- PI3KクラスIIアイソフォームPI3K-C2αを介した血管平滑筋収縮における"Ca^-induced Ca^-sensitization"
- スフィンゴシー1-リン 酸・Edg受容体システムの血管作用
- ラット頚動脈バルーン血管障害モデルにおけるcdc2, cdk2アンチセンスオリゴヌクレオチドによる血管平滑筋増殖の抑制 : 第58回日本循環器学会学術集会
- PE-208 Development of Decompensated Cardiac Hypertrophy in Transgenic Mice That Overexpress S1P1 under the Control of Alpha Smooth Muscle Actin Promoter(Cardiac hypertrophy, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation
- PJ-366 Cyclic AMP-mediated Inhibitory Regulation of Rac Activation and Cell Migration by the EP2 subtype of Prostagalandin E2 (PGE2) Receptors in Vascular Smooth Muscle(Molecular Biology, Vascular 2 (H) : PJ61)(Poster Session (Japanese))
- P648 Predominance of Arterial Baroreflex Over Cardiopulmonary Baroreflex During Ventricular Tachycardia
- Rho-ROCK と平滑筋収縮
- P321 血管平滑筋細胞におけるアンギオテンシンIIによるRas活性化機構
- 細胞周期進行の情報伝達機構
- スフインゴシン-1-リン酸受容体によるがん浸潤・転移の制御 : 受容体サブタイブ得意的な促進・抑制二方向性制御とその分子機構
- Signal Transduction of Cell-Cycle Regulation : Its Temporo-Spacial Architecture
- 第56回中部日本生理学会
- PI3-キナーゼクラス2αアイソフォームを介したカルシウムイオンによる血管収縮活性化の新機構 (特集・血管壁)
- G1早期におけるRasの役割-MAPK活性化を介したcyclin D1発現
- Cキナーゼによる血管内皮細胞増殖の2相性制御 : ポスター発表 : 第57回日本循環器学会学術集会
- EdgファミリーS1P受容体によるRhoファミリーG蛋白質と細胞運動の制御 (マイクロドメイン形成と細胞のシグナリング--スフィンゴ脂質の新しい生物機能) -- (第4部 スフィンゴシン1-リン酸とその受容体)
- ATPの血管作用 (特集 情報伝達物質としてのATP)
- スフィンゴシン1-リン酸シグナル伝達系の心血管系における機能 (特集 リン脂質代謝と脂質メディエーター研究の最新の成果) -- (リゾリン脂質を中心とした脂質メディエーター)
- 医学教育改革雑感
- PDGF-Bを標的とした遺伝子導入による血管障害後の内膜肥厚に対する病態解明と治療 : 受容体細胞外領域を用いた選択的な増殖因子の抑制
- 内膜肥厚に関与する成長因子PDGF-B鎖の遺伝子発現調節におけるアンギオテンシンIIの役割
- スフィンゴシン1-リン酸シグナル伝達系の心血管系における機能
- Deletion of sphingosine-1-phosphate receptor-2 inhibits proinflammatory activities of macrophages and atherosclerosis in apoE-deficient mice
- ApoE欠損動脈硬化マウスにおいてスフィンゴシン-1-リン2型受容体遺伝子欠失はマクロファージの炎症活性と動脈硬化を抑制する
- クラスIIα型PI3キナーゼC2αは血管形成に必須である
- A Case Report of a Renal Mixed Epithelial and Stromal Tumor in a Heterozygous S1P2 Receptor Deficient Mouse(Pathology)